|
DNAJC8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.795880E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.241910E-02 |
| Normal-vs-Stage2 |
6.998600E-03 |
| Normal-vs-Stage3 |
1.09639999967825E-07 |
| Normal-vs-Stage4 |
3.789600E-04 |
| Stage1-vs-Stage2 |
2.822600E-01 |
| Stage1-vs-Stage3 |
2.02329999999806E-05 |
| Stage1-vs-Stage4 |
3.366200E-02 |
| Stage2-vs-Stage3 |
6.625800E-02 |
| Stage2-vs-Stage4 |
5.499200E-01 |
| Stage3-vs-Stage4 |
1.999620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.020490E-04 |
| Normal-vs-AfricanAmerican |
1.582240E-02 |
| Normal-vs-Asian |
9.952000E-01 |
| Caucasian-vs-AfricanAmerican |
6.404600E-01 |
| Caucasian-vs-Asian |
1.702760E-01 |
| AfricanAmerican-vs-Asian |
3.146200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5667000000017E-05 |
| Normal-vs-Female |
1.127650E-02 |
| Male-vs-Female |
1.701750E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.601600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.195100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.197230E-04 |
| Normal-vs-Age(81-100Yrs) |
4.023500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.977800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.959200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.034400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.210800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.088400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.473200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.082000E-01 |
| Normal-vs-Grade 2 |
5.788400E-02 |
| Normal-vs-Grade 3 |
2.35759999966945E-07 |
| Normal-vs-Grade 4 |
1.97808999999882E-05 |
| Grade 1-vs-Grade 2 |
5.436000E-02 |
| Grade 1-vs-Grade 3 |
5.579200E-04 |
| Grade 1-vs-Grade 4 |
6.10249999999368E-05 |
| Grade 2-vs-Grade 3 |
1.29810000004671E-06 |
| Grade 2-vs-Grade 4 |
7.561800E-04 |
| Grade 3-vs-Grade 4 |
5.980800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.469000E-01 |
| Normal-vs-ccB subtype |
1.53420000037485E-08 |
| ccA subtype-vs-ccB subtype |
1.52200030356653E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.151730E-04 |
| Normal-vs-N1 |
7.239700E-04 |
| N0-vs-N1 |
2.210000E-01 |
|
|
